Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral saffron for prevention of renal injury in septic shock
IRCT20200408046990N19Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of saffron in septic shock and acute kidney failure (AKF), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Renal injury prevention. Started Jun 2025; status: recruiting.
02
Drugs
saffron
03
Conditions
septic shockacute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20200408046990N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046990N19.